Glynn Capital Management LLC reduced its position in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) by 4.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,740,597 shares of the company’s stock after selling 115,428 shares during the period. Oscar Health makes up approximately 13.5% of Glynn Capital Management LLC’s portfolio, making the stock its largest position. Glynn Capital Management LLC’s holdings in Oscar Health were worth $39,382,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Quarry LP raised its holdings in Oscar Health by 439.8% during the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after purchasing an additional 1,469 shares in the last quarter. Tsfg LLC purchased a new position in Oscar Health during the third quarter worth about $38,000. Jones Financial Companies Lllp raised its holdings in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio purchased a new position in Oscar Health during the first quarter worth about $30,000. Finally, Fifth Third Bancorp grew its position in Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after buying an additional 1,413 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several brokerages have weighed in on OSCR. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research report on Tuesday, April 21st. Wolfe Research began coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They set a “peer perform” rating on the stock. Zacks Research upgraded shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, May 7th. Raymond James Financial upgraded shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price on the stock in a research report on Thursday, February 12th. Finally, Barclays upped their target price on shares of Oscar Health from $21.00 to $30.00 and gave the stock an “equal weight” rating in a research report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $19.22.
Insider Activity at Oscar Health
In other Oscar Health news, CEO Mark T. Bertolini purchased 1,000,000 shares of the stock in a transaction dated Monday, April 6th. The shares were acquired at an average cost of $11.92 per share, for a total transaction of $11,920,000.00. Following the completion of the transaction, the chief executive officer directly owned 10,196,876 shares of the company’s stock, valued at $121,546,761.92. This trade represents a 10.87% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Richard Scott Blackley sold 100,000 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the completion of the sale, the chief financial officer owned 1,216,660 shares in the company, valued at $28,177,845.60. This represents a 7.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 24.39% of the stock is owned by corporate insiders.
Oscar Health Trading Up 1.7%
Shares of OSCR opened at $22.36 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. The firm’s 50-day moving average is $17.21 and its two-hundred day moving average is $15.73. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $25.58. The firm has a market capitalization of $6.74 billion, a P/E ratio of -37.90, a PEG ratio of 1.54 and a beta of 2.34.
Oscar Health (NYSE:OSCR – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.96. The company had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The firm’s revenue for the quarter was up 52.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.92 earnings per share. On average, research analysts predict that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.
About Oscar Health
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
Featured Articles
- Five stocks we like better than Oscar Health
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
